These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26817139)
1. Longitudinal Validation of the Spanish Version of the Health-Related Quality of Life Questionnaire for Hymenoptera Venom Allergy (HRQLHA). Alfaya T; Vega A; Domínguez-Noche C; Ruiz B; Marqués L; Sánchez-Morillas L J Investig Allergol Clin Immunol; 2015; 25(6):426-30. PubMed ID: 26817139 [TBL] [Abstract][Full Text] [Related]
2. Cross-Sectional Validation of a Quality of Life Questionnaire in Spanish for Patients Allergic to Hymenoptera Venom. Armisén M; Guspi R; Alfaya T; Cruz S; Fernández S; Domínguez-Noche C; Alonso A; Dalmau G; Marqués L; Vega A J Investig Allergol Clin Immunol; 2015; 25(3):176-82. PubMed ID: 26182683 [TBL] [Abstract][Full Text] [Related]
3. Tolerated sting challenge in patients on Hymenoptera venom immunotherapy improves health-related quality of life. Koschel DS; Schmies M; Weber CN; Höffken G; Balck F J Investig Allergol Clin Immunol; 2014; 24(4):226-30. PubMed ID: 25219104 [TBL] [Abstract][Full Text] [Related]
5. Age-dependent sting recurrence and outcome in immunotherapy-treated children with anaphylaxis to Hymenoptera venom. Stritzke AI; Eng PA Clin Exp Allergy; 2013 Aug; 43(8):950-5. PubMed ID: 23889248 [TBL] [Abstract][Full Text] [Related]
6. Expression of Th1, Th2, lymphocyte trafficking and activation markers on CD4+ T-cells of Hymenoptera allergic subjects and after venom immunotherapy. Cabrera CM; Urra JM; Alfaya T; Roca Fde L; Feo-Brito F Mol Immunol; 2014 Nov; 62(1):178-85. PubMed ID: 25004111 [TBL] [Abstract][Full Text] [Related]
14. [Influence of venom immunotherapy on anxiety level of being re-stung]. Sacha M; Czarnobilska E; Stobiecki M; Dyga W Przegl Lek; 2012; 69(12):1261-5. PubMed ID: 23750435 [TBL] [Abstract][Full Text] [Related]
15. Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients. Goldberg A; Confino-Cohen R; Mekori YA Ann Allergy Asthma Immunol; 1995 Jul; 75(1):30-2. PubMed ID: 7621057 [TBL] [Abstract][Full Text] [Related]
16. When can immunotherapy for insect sting allergy be stopped? Müller UR; Ring J J Allergy Clin Immunol Pract; 2015; 3(3):324-8; quiz 329-30. PubMed ID: 25956311 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, diagnosis, and treatment of Hymenoptera venom allergy in mastocytosis patients. Niedoszytko M; Bonadonna P; Oude Elberink JN; Golden DB Immunol Allergy Clin North Am; 2014 May; 34(2):365-81. PubMed ID: 24745680 [TBL] [Abstract][Full Text] [Related]
18. Epidemiologic observations on Hymenoptera allergy in Spain: the Alergológica-2005 study. Marqués L; Vega A; Muñoz E; Moreno-Ancillo A J Investig Allergol Clin Immunol; 2009; 19 Suppl 2():51-5. PubMed ID: 19530419 [TBL] [Abstract][Full Text] [Related]
19. The Lights and the Shadows of Controlled Sting Challenge With Hymenoptera. Ruiz-León B; Martínez San Ireneo M; de la Roca F; Arenas L; Alfaya Arias T; Cordobés C; Marqués L; Vega A; Moreno-Aguilar C J Investig Allergol Clin Immunol; 2022 Oct; 32(5):357-366. PubMed ID: 35735250 [TBL] [Abstract][Full Text] [Related]